Cardiovascular Morbidity and Mortality and Renal Artery Stenosis

Overview

Journal Prog Cardiovasc Dis

Specialty Cardiology & Vascular Diseases

Date 2009 Nov 18

PMID 19917335

Citations 10

Authors

William R Colyer Jr

Christopher J Cooper

Affiliations

Soon will be listed here.

Abstract

Renal artery stenosis (RAS) is a common manifestation of atherosclerosis and is associated with many other atherosclerotic conditions. Cardiovascular morbidity and mortality is increased among patients with RAS. This increase is likely due in part to the associated disease states; however, RAS itself may also contribute. Current strategies to limit cardiovascular morbidity and mortality in RAS include various pharmacologic interventions targeting both RAS atherosclerosis in general. Additionally, revascularization has been advocated; however, clear data are lacking. Ongoing clinical trials such as the Cardiovascular Outcomes in Renal Atherosclerotic Lesions (CORAL) trial will ultimately help to determine the best strategies to limit the morbidity and mortality associated with RAS.

Citing Articles

Predictors of complications and extended length of stay following percutaneous transluminal renal artery angioplasty.

Mustafa A, Wei C, Khan S, Rizvi T, Grovu R, Khan D Medicine (Baltimore). 2025; 103(52):e41017.

PMID: 39969339 PMC: 11688026. DOI: 10.1097/MD.0000000000041017.

Cardiovascular Disease Prevention in Patients With Atherosclerotic Renovascular Disease-Induced Resistant Hypertension: Further Considerations for 24-Hour Blood Pressure Profiles.

Narita K, Hoshide S, Kario K J Am Heart Assoc. 2022; 11(17):e025901.

PMID: 35975740 PMC: 9496410. DOI: 10.1161/JAHA.122.025901.

Effects of Renal Impairment on the Pharmacokinetics of the Dual GIP and GLP-1 Receptor Agonist Tirzepatide.

Urva S, Quinlan T, Landry J, Martin J, Loghin C Clin Pharmacokinet. 2021; 60(8):1049-1059.

PMID: 33778934 PMC: 8332596. DOI: 10.1007/s40262-021-01012-2.

Restenosis Rates After Drug-Eluting Stent Treatment for Stenotic Small-Diameter Renal Arteries.

Jundt M, Takahashi E, Harmsen W, Misra S Cardiovasc Intervent Radiol. 2019; 42(9):1293-1301.

PMID: 31267151 PMC: 6679807. DOI: 10.1007/s00270-019-02264-z.

Biopolymer-delivered vascular endothelial growth factor improves renal outcomes following revascularization.

Guise E, Engel J, Williams M, Mahdi F, Bidwell 3rd G, Chade A Am J Physiol Renal Physiol. 2019; 316(5):F1016-F1025.

PMID: 30892933 PMC: 6580255. DOI: 10.1152/ajprenal.00607.2018.

References

Schwarzwalder U, Zeller T . Critical review of indications for renal artery stenting: do randomized trials give the answer?. Catheter Cardiovasc Interv. 2009; 74(2):251-6. DOI: 10.1002/ccd.22073. View

Wright R, Reeder G, Herzog C, Albright R, Williams B, Dvorak D . Acute myocardial infarction and renal dysfunction: a high-risk combination. Ann Intern Med. 2002; 137(7):563-70. DOI: 10.7326/0003-4819-137-7-200210010-00007. View

Jean W, Zwicke D, Port S, Schmidt D, Bajwa T . High incidence of renal artery stenosis in patients with coronary artery disease. Cathet Cardiovasc Diagn. 1994; 32(1):8-10. DOI: 10.1002/ccd.1810320103. View

Schmidt-Ott K, Kagiyama S, Phillips M . The multiple actions of angiotensin II in atherosclerosis. Regul Pept. 2000; 93(1-3):65-77. DOI: 10.1016/s0167-0115(00)00178-6. View

Levin A, Linas S, Luft F, Chapman A, Textor S . Controversies in renal artery stenosis: a review by the American Society of Nephrology Advisory Group on Hypertension. Am J Nephrol. 2007; 27(2):212-20. DOI: 10.1159/000101000. View

Mann J, Gerstein H, Dulau-Florea I, Lonn E . Cardiovascular risk in patients with mild renal insufficiency. Kidney Int Suppl. 2003; (84):S192-6. DOI: 10.1046/j.1523-1755.63.s84.27.x. View

Watson P, Hadjipetrou P, Cox S, Piemonte T, Eisenhauer A . Effect of renal artery stenting on renal function and size in patients with atherosclerotic renovascular disease. Circulation. 2000; 102(14):1671-7. DOI: 10.1161/01.cir.102.14.1671. View

EYLER W, Clark M, GARMAN J, RIAN R, MEININGER D . Aniography of the renal areas including a comparative study of renal arterial stenoses in patients with and without hypertension. Radiology. 1962; 78:879-92. DOI: 10.1148/78.6.879. View

Sawicki P, Kaiser S, Heinemann L, Frenzel H, Berger M . Prevalence of renal artery stenosis in diabetes mellitus--an autopsy study. J Intern Med. 1991; 229(6):489-92. DOI: 10.1111/j.1365-2796.1991.tb00382.x. View

10.

Swartbol P, Thorvinger B, Parsson H, Norgren L . Renal artery stenosis in patients with peripheral vascular disease and its correlation to hypertension. A retrospective study. Int Angiol. 1992; 11(3):195-9. View

11.

Hackam D, Duong-Hua M, Mamdani M, Li P, Tobe S, Spence J . Angiotensin inhibition in renovascular disease: a population-based cohort study. Am Heart J. 2008; 156(3):549-55. DOI: 10.1016/j.ahj.2008.05.013. View

12.

Olin J, Melia M, Young J, Graor R, Risius B . Prevalence of atherosclerotic renal artery stenosis in patients with atherosclerosis elsewhere. Am J Med. 1990; 88(1N):46N-51N. View

13.

Leertouwer T, Derkx F, Pattynama P, Deinum J, van Dijk L, Schalekamp M . Functional effects of renal artery stent placement on treated and contralateral kidneys. Kidney Int. 2002; 62(2):574-9. DOI: 10.1046/j.1523-1755.2002.00456.x. View

14.

Kalra P, Guo H, Kausz A, Gilbertson D, Liu J, Chen S . Atherosclerotic renovascular disease in United States patients aged 67 years or older: risk factors, revascularization, and prognosis. Kidney Int. 2005; 68(1):293-301. DOI: 10.1111/j.1523-1755.2005.00406.x. View

15.

Onuigbo M, Onuigbo N . Worsening renal failure in older chronic kidney disease patients with renal artery stenosis concurrently on renin angiotensin aldosterone system blockade: a prospective 50-month Mayo-Health-System clinic analysis. QJM. 2008; 101(7):519-27. DOI: 10.1093/qjmed/hcn039. View

16.

Conlon P, Athirakul K, Kovalik E, Schwab S, Crowley J, Stack R . Survival in renal vascular disease. J Am Soc Nephrol. 1998; 9(2):252-6. DOI: 10.1681/ASN.V92252. View

17.

van Jaarsveld B, Krijnen P, Pieterman H, Derkx F, Deinum J, Postma C . The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. N Engl J Med. 2000; 342(14):1007-14. DOI: 10.1056/NEJM200004063421403. View

18.

LOUIE J, Isaacson J, Zierler R, Bergelin R, Strandness Jr D . Prevalence of carotid and lower extremity arterial disease in patients with renal artery stenosis. Am J Hypertens. 1994; 7(5):436-9. DOI: 10.1093/ajh/7.5.436. View

19.

Choudhri A, Cleland J, Rowlands P, Tran T, McCarty M, Al-Kutoubi M . Unsuspected renal artery stenosis in peripheral vascular disease. BMJ. 1990; 301(6762):1197-8. PMC: 1664347. DOI: 10.1136/bmj.301.6762.1197. View

20.

Wheeler D, Townend J, Landray M . Cardiovascular risk factors in predialysis patients: baseline data from the Chronic Renal Impairment in Birmingham (CRIB) study. Kidney Int Suppl. 2003; (84):S201-3. DOI: 10.1046/j.1523-1755.63.s84.45.x. View